Seguimiento a largo plazo de mujeres tratadas con implantes anticonceptivos de levonorgestrel Norplant.

S. Díaz, M. Pavez, P. Miranda, E. Quinteros, H. B. Croxatto

Resultado de la investigación: Article

Resumen

This report describe the long-term follow-up of 376 women who received Norplant implants in the period october 1974 through may 1979. One-hundred-and-ten subjects received replacement implants after variable lengths of use of the first set. The average levonorgestrel plasma levels declined steadily through eight years of use of Norplant capsules (r = -937). Values were 0.35 ng/ml, 0.29 ng/ml and 0.22 ng/ml at treatment years 1, 5 and 8, respectively. Levonorgestrel plasma levels after replacement with a second set of implants were similar to those observed after the first insertion, either when placed in the same site as the first set or in a different area. The levonorgestrel half-life after implant removal was 42 +/- 16 h (X +/- S.E.) and only trace amounts are detected after 96 h. Nineteen pregnancies occurred during 18,530 woman-months of use of the first set of implants, eleven of them during years 6 through 8 of treatment. The Pearl Index for the first years of Norplant implants use was 0.63. No pregnancy has occurred in 5.020 woman-months observed during treatment with a second set of capsules. Fifty-six women (14.9%) out of 376 acceptors of the first implant and 12 (10.9%) out of 110 acceptors of the replacement implants were terminated for other medical reasons, mainly side effects commonly associated with hormonal contraception. Removals for bleeding problems occurred in 5.6% and 3.6% of the acceptors of the first and second implant, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Idioma originalSpanish
Páginas (desde-hasta)323-331
Número de páginas9
PublicaciónRevista Chilena de Obstetricia y Ginecologia
Volumen54
N.º5
EstadoPublished - 1989

Huella dactilar

Levonorgestrel
Contraceptive Agents
Capsules
Pregnancy
Contraception
Half-Life
Therapeutics
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Citar esto

@article{8fb4693a82294b46b12ec8f4883ea193,
title = "Seguimiento a largo plazo de mujeres tratadas con implantes anticonceptivos de levonorgestrel Norplant.",
abstract = "This report describe the long-term follow-up of 376 women who received Norplant implants in the period october 1974 through may 1979. One-hundred-and-ten subjects received replacement implants after variable lengths of use of the first set. The average levonorgestrel plasma levels declined steadily through eight years of use of Norplant capsules (r = -937). Values were 0.35 ng/ml, 0.29 ng/ml and 0.22 ng/ml at treatment years 1, 5 and 8, respectively. Levonorgestrel plasma levels after replacement with a second set of implants were similar to those observed after the first insertion, either when placed in the same site as the first set or in a different area. The levonorgestrel half-life after implant removal was 42 +/- 16 h (X +/- S.E.) and only trace amounts are detected after 96 h. Nineteen pregnancies occurred during 18,530 woman-months of use of the first set of implants, eleven of them during years 6 through 8 of treatment. The Pearl Index for the first years of Norplant implants use was 0.63. No pregnancy has occurred in 5.020 woman-months observed during treatment with a second set of capsules. Fifty-six women (14.9{\%}) out of 376 acceptors of the first implant and 12 (10.9{\%}) out of 110 acceptors of the replacement implants were terminated for other medical reasons, mainly side effects commonly associated with hormonal contraception. Removals for bleeding problems occurred in 5.6{\%} and 3.6{\%} of the acceptors of the first and second implant, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)",
author = "S. D{\'i}az and M. Pavez and P. Miranda and E. Quinteros and Croxatto, {H. B.}",
year = "1989",
language = "Spanish",
volume = "54",
pages = "323--331",
journal = "Revista Chilena de Obstetricia y Ginecologia",
issn = "0048-766X",
publisher = "Sociedad Chilena de Obstetricia y Ginecologia",
number = "5",

}

Seguimiento a largo plazo de mujeres tratadas con implantes anticonceptivos de levonorgestrel Norplant. / Díaz, S.; Pavez, M.; Miranda, P.; Quinteros, E.; Croxatto, H. B.

En: Revista Chilena de Obstetricia y Ginecologia, Vol. 54, N.º 5, 1989, p. 323-331.

Resultado de la investigación: Article

TY - JOUR

T1 - Seguimiento a largo plazo de mujeres tratadas con implantes anticonceptivos de levonorgestrel Norplant.

AU - Díaz, S.

AU - Pavez, M.

AU - Miranda, P.

AU - Quinteros, E.

AU - Croxatto, H. B.

PY - 1989

Y1 - 1989

N2 - This report describe the long-term follow-up of 376 women who received Norplant implants in the period october 1974 through may 1979. One-hundred-and-ten subjects received replacement implants after variable lengths of use of the first set. The average levonorgestrel plasma levels declined steadily through eight years of use of Norplant capsules (r = -937). Values were 0.35 ng/ml, 0.29 ng/ml and 0.22 ng/ml at treatment years 1, 5 and 8, respectively. Levonorgestrel plasma levels after replacement with a second set of implants were similar to those observed after the first insertion, either when placed in the same site as the first set or in a different area. The levonorgestrel half-life after implant removal was 42 +/- 16 h (X +/- S.E.) and only trace amounts are detected after 96 h. Nineteen pregnancies occurred during 18,530 woman-months of use of the first set of implants, eleven of them during years 6 through 8 of treatment. The Pearl Index for the first years of Norplant implants use was 0.63. No pregnancy has occurred in 5.020 woman-months observed during treatment with a second set of capsules. Fifty-six women (14.9%) out of 376 acceptors of the first implant and 12 (10.9%) out of 110 acceptors of the replacement implants were terminated for other medical reasons, mainly side effects commonly associated with hormonal contraception. Removals for bleeding problems occurred in 5.6% and 3.6% of the acceptors of the first and second implant, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

AB - This report describe the long-term follow-up of 376 women who received Norplant implants in the period october 1974 through may 1979. One-hundred-and-ten subjects received replacement implants after variable lengths of use of the first set. The average levonorgestrel plasma levels declined steadily through eight years of use of Norplant capsules (r = -937). Values were 0.35 ng/ml, 0.29 ng/ml and 0.22 ng/ml at treatment years 1, 5 and 8, respectively. Levonorgestrel plasma levels after replacement with a second set of implants were similar to those observed after the first insertion, either when placed in the same site as the first set or in a different area. The levonorgestrel half-life after implant removal was 42 +/- 16 h (X +/- S.E.) and only trace amounts are detected after 96 h. Nineteen pregnancies occurred during 18,530 woman-months of use of the first set of implants, eleven of them during years 6 through 8 of treatment. The Pearl Index for the first years of Norplant implants use was 0.63. No pregnancy has occurred in 5.020 woman-months observed during treatment with a second set of capsules. Fifty-six women (14.9%) out of 376 acceptors of the first implant and 12 (10.9%) out of 110 acceptors of the replacement implants were terminated for other medical reasons, mainly side effects commonly associated with hormonal contraception. Removals for bleeding problems occurred in 5.6% and 3.6% of the acceptors of the first and second implant, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

UR - http://www.scopus.com/inward/record.url?scp=0024917148&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 323

EP - 331

JO - Revista Chilena de Obstetricia y Ginecologia

JF - Revista Chilena de Obstetricia y Ginecologia

SN - 0048-766X

IS - 5

ER -